[email protected] +44 20 8123 2220 (UK) +1 732 587 5005 (US) Contact Us | FAQ |

2019 Nucleic Acid Testing Market Competitive Landscape: Strategic Assessments of Leading Suppliers

April 2019 | 549 pages | ID: 20681AE7908EN
Venture Planning Group

US$ 3,500.00

E-mail Delivery (PDF)

Download PDF Leaflet

Accepted cards
Wire Transfer
Checkout Later
Need Help? Ask a Question
This 549-page report presents an overview of the clinical significance and market needs for major current and emerging NAT assays, as well as extensive listings of companies developing and marketing innovative Technologies and products.

This report also presents strategic assessments of current and emerging suppliers of nucleic acid testing products, including their sales, product portfolios, marketing tactics, technological know-how, new products in R&D, collaborative arrangements and business strategies.

Contains 549 pages and 22 tables
Microbiology/Infectious Diseases
    a. Overview
    b. Major Infectious Diseases
      AIDS
      Structure and Composition
      Classification
      AIDS Origins
      Animal Lentivirus Systems
      Virus Receptors
      HIV Infections in Humans
      Pathogenesis and Pathology
      CD4T Lymphocytes and Memory Cells
      Monocytes and Macrophages
      Lymphoid Organs
      Neural Cells
      Viral Coinfections
      Clinical Findings
      Plasma Viral Load
      Pediatric AIDS
      Neurologic Disease
      Opportunistic Infections
      Cancer
      Immunity
      Virus Isolation
      Serology
      Viral Nucleic Acid/Antigen Detection
      Epidemiology
      Worldwide Spread of AIDS
      United States
      Routes of Transmission
      DNA Probes
      Overview
      Quantitative PCR
      In Situ PCR
      Needed Improvements
      Viral Load/Drug Resistance Testing
      Genotype and Phenotype Testing
      Blood Banking Considerations
      Adenovirus
      Background
      Diagnostic Tests
      Vaccines and Drugs
      Adeno-Associated Viruses (AAV)
      Anthrax/Bacillus Anthracis
      Background
      Diagnostic Tests
      Vaccines and Drugs
      Babesiosis
      Background
      BEA and Other Bartonella Diseases
      Background
      Diagnostic Tests
      Vaccines and Drugs
      Chagas Disease
      Background
      Campylobacter
      Background
      Diagnostic Tests
      Culture Identification
      Vaccines and Drugs
      Chlamydia
      Background
      Chlamydia psittaci
      Chlmaydia pneumoniae
      Chlamydia trachomatis
      Diagnostic Tests
      Vaccines
      Major Commercial and Academic Players
      Bayer
      Disease Sciences/Bio Tec Global
      Imperial College School of Medicine
      Ortho-Clinical Diagnostics
      Pall
      ProMetic Life Sciences
      Proteome Sciences/Idexx
      Q-One Biotech
      Serono
      U.S. Agricultural Research Service
      Drugs
      Vaccines
      Cytomegalovirus
      Background
      Chorioretinitis
      Gastrointestinal
      Central Nervous System Disease
      Diagnostic Tests
      Vaccines and Drugs
      Ebola Virus
      Background
      Epidemiology
      Clinical Syndromes
      Diagnostic Tests
      Vaccines and Drugs
      EchoVirus
      Background
      Acute Aseptic Meningitisis
      Encephalitis
      Exanthems
      Respiratory Disease
      Myopericarditis
      Neonatal Infections
      Diagnostic Tests
      Vaccines and Drugs
      Encephalitis
      Background
      Diagnostic Tests
      Vaccines and Drugs
      Enteroviruses
      Background
      Diagnostic Tests
      Viral Isolation and Identification
      Antibody Tests
      Vaccines and Drugs
      Epstein-Barr Virus
      Background
      Diagnostic Tests
      Vaccines and Drugs
      Gonorrhea
      Background
      Diagnostic Tests
      Vaccines and Drugs
      Hepatitis
      Hepatitis A
      Hepatitis B
      Structure and Composition
      Replication
      Hepatitis C
      Hepatitis D (Delta)
      Hepatitis E
      Hepatitis G
      Hepatitis Infections Pathology
      Clinical Findings
      Laboratory Tests
      Herpes Simplex Virus
      Background
      Diagnostic Tests
      Vaccines and Drugs
      Legionella
      Background
      Diagnostic Tests
      Vaccines and Drugs
      Lyme Disease
      Background
      Clinical Description
      Clinical Case Definition
      Laboratory Criteria for Diagnosis
      Case Classification
      Diagnostic Tests
      Vaccines and Drugs
      Malaria
      Mycoplasma
      Background
      Ureaplasma Urealyticum & Mycoplasma Hominis
      Diagnostic Tests
      Vaccines and Drugs
      Papillomaviruses/HPV
      Background
      HPV in Cancer
      Cervical Neoplasm
      Diagnostic Tests
      Vaccines and Drugs
      Prevention
      Parvovirus B19
      Background
      Microbiology
      Epidemiology
      Clinical Syndromes
      Erythema Infectiosum (Slapped Cheek)
      Adult Polyarthropathy
      Transient Aplastic Crisis
      Transient Pancytopenia
      Red Cell Aplasia in Immunocompromised
      Perinatal Infections
      Diagnostic Test
      Vaccines and Drugs
      Pneumonia
      Background
      Diagnostic Tests
      Vaccines and Drugs
      Polyomaviruses
      Background
      Diagnostic Tests
      Vaccines and Drugs
      Salmonellosis
      Background
      Diagnostic Tests
      Vaccines and Drugs
      Shigellosis
      Background
      Diagnostic Tests
      Vaccines and Drugs
      Streptococci
      Background
      Diagnostic Tests
      Vaccines and Drugs
      Group A Streptococci
      Group B Streptococci
      Toxoplasmosis
      Background
      Diagnostic Tests
      Vaccines a
      West Nile Virus
      Background
      Clinical Syndromes
      Diagnostic Tests
      Vaccines and Drugs
      Yersinia
      Background
      Diagnostic Tests
      Vaccines and Drugs
      Antibiotic Susceptibility Cancer Testing
    a. Overview
    b. Major Cancer Types
      Prostate
      Lung
      Colon and Rectum
      Breast
      Skin
      Uterine
      Leukemia
      Oral
    c. Oncogenes
      Abl/abl-bcr
      AIB1
      BCL-2
      BRCA1
      CD44
      C-fos
      C-myb
      C-myc
      CYP17
      Erb-B
      HPC1
      N-myc
      P40
      P51
      P53
      PIK3CA
      PTI-1
      Ras
      Reg
      Sis
      Src
Genetic Diseases
    a. Overview
    b. Nucleic Acid Amplification
    c. Chromosome Imaging
    d. Genomics Technologies
    e. Proteomics Technologies
    f. Current Pharmacogenomic Tests
    g. Future Pharmacogenomic Testing
    h. Major Diseases
      Achondroplasia
      Autosomal Dominant Polycystic Kidney Disease
      Cancer
      Cosmetogenomics
      Cystic Fibrosis
      Down's Syndrome
      Duchenne and Becker Muscular Dystrophy
      Factor V (Leiden)
      Factor IX Deficiency
      Fragile X Syndrome
      Heart Disease
      Hemochomatosis
      Hemophilia
      Huntington's Disease
      Maternal-Fetal Incompatibility
      Multiple Endocrine Neoplasia
      Phenylketonuria (PKU)
      Polycystic Kidney Disease (PKD)
      Prenatal Screening
      Retinitis Pigmentosa
      Retinoblastoma
      Sickle Cell Anemia
      Spinal Muscular Atrophy
      Vitamin B12 Metabolism
    i. Social Issues and Concerns Forensic Testing
    a. Overview
    b. Multilocus and Single Locus Probes
      Multilocus Probes
      Single Locus Probes
      PCR and RFLP
    c. The FBI
    d. DNA Profile Data Banks
      U.S.A.
      U.K.
    e. Judicial Implementation
    f. Major Crime Categories
    g. Factors Contributing to the DNA Probe Market Expansion
      Technology Availability
      Use of Hair as Evidence
    h. Wildlife Forensics
Paternity Testing/HLA Typing
Other Applications
    a. Disease Susceptibility Testing
    b. Cardiovascular Diseases
    c. Diabetes
    d. Alzheimer's Disease
    e. Periodontal Disease
    f. Plasma Purification
    g. Organ Transplantation
    h. Water Contamination
    i. Other

COMPETITIVE PROFILES

Abbott
Affymetrix
Agilent Technologies
Applied Gene Technologies
Arca Biopharma
Beckman Coulter/Danaher
Becton Dickinson
Biokit
BioMerieux
Bio-Rad
Biotest
Cepheid
CellMark Forensics/LabCorp
Decode Genetics
Diadexus
Elitech Group
Eiken
Enzo
Exact Sciences
Fujirebio
Grifols
Hologic/Gen-Probe
Illumina
Kreatech/Leica
Li-Cor Biosciences
Monogram Biosciences
Myriad Genetics
Ortho-Clinical Diagnostics
Perkin Elmer/Caliper
Proteome Sciences
Qiagen
Roche
Scienion
Sequenom
Shimadzu
Siemens
Sierra Molecular
Takara Bio
Tecan Group
Thermo Fisher

LIST OF TABLES

Major Companies Developing or Marketing AIDS Molecular Diagnostic And Other Direct Identification Tests
Major Companies Developing or Marketing Adenovirus Molecular Diagnostic And Other Direct Identification Tests
Major Companies Developing or Marketing Campylobacter Molecular Diagnostic And Other Direct Identification Tests
Major Companies Developing or Marketing Chlamydia Molecular Diagnostic And Other Direct Identification Tests
Major Companies Developing or Marketing CMV Molecular Diagnostic And Other Direct Identification Tests
Major Companies Developing or Marketing EBV Molecular Diagnostic And Other Direct Identification Tests
Major Companies Developing or Marketing Gonorrhea Molecular Diagnostic And Other Direct Identification Tests
Major Companies Developing or Marketing Hepatitis Molecular Diagnostic And Other Direct Identification Tests
Major Companies Developing or Marketing Herpes Molecular Diagnostic And Other Direct Identification Tests
Major Companies Developing or Marketing Legionella Molecular Diagnostic And Other Direct Identification Tests
Major Companies Developing or Marketing Lyme Disease Molecular Diagnostic And Other Direct Identification Tests
Major Companies Developing or Marketing Mycoplasma Molecular Diagnostic And Other Direct Identification Tests
Major Companies Developing or Marketing Papilloma Virus Molecular Diagnostic And Other Direct Identification Tests
Major Companies Developing or Marketing Pneumonia Molecular Diagnostic And Other Direct Identification Tests
Major Companies Developing or Marketing Salmonella Molecular Diagnostic And Other Direct Identification Tests
Major Companies Developing or Marketing Shigella Molecular Diagnostic And Other Direct Identification Tests
Major Companies Developing or Marketing Streptococci Molecular Diagnostic And Other Direct Identification Tests
Major Companies Developing or Marketing Toxoplasmosis Molecular Diagnostic And Other Direct Identification Tests
Major Companies Developing or Marketing Tuberculosis Molecular Diagnostic And Other Direct Identification Tests
Oncogenes Potential Application in Cancer Diagnosis
Major Companies Developing or Marketing Cancer Molecular Diagnostic Tests
Major Companies Developing or Marketing Molecular Diagnostic Test For Genetic Diseases


More Publications